Dr. Ling-Xin Chen, MD

Dr. Chen practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Chen's NPI, 1962633438, was assigned on August 1, 2009. Dr. Chen graduated from University of Maryland School of Medicine - Baltimore in 2009. Dr. Chen's California license number on file is A142029.

Dr. Chen's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Chen's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Chen is also affiliated with University of Chicago Medical Center. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chen is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chen's licenses on file in 2 states: California and Illinois.

CMS data shows 610 Medicare services from Dr. Chen across 9 procedure codes in 2024, for 192 Medicare patients. Medicare paid $36,190 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Chen in 2024. The largest group is under 65, with 102 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 58% are also on Medicaid. Their average risk score is 5.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 56, with 44% women.

In 2024, Dr. Chen wrote 1,335 Medicare Part D claims for 176 patients. 86% of them were for generic drugs. CMS names the drug for 1,132 of them, across 33 drugs with 11 or more claims each, at $130,064 in total drug cost. In 2023, CMS named 989 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 16 papers to Dr. Chen, published from 2017 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Kidney and Biopsy. Dr. Chen has published most often in Transplantation. Dr. Chen's most frequent co-authors are Yihung Huang, MD, Kuang-Yu Jen, MD, PhD and Junichiro Sageshima, MD.

Dmand AI links Dr. Chen to 1 clinical trial. Conditions studied include Neurotoxicity Syndromes and Poisoning.

CMS Open Payments shows 8 general payments to Dr. Chen from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $218.

Dr. Chen graduated from University of Maryland School of Medicine - Baltimore in 2009.

Dr. Chen is in network with 7 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.